Tags: Axxam


Inflammation, The Driver of Alzheimer's Disease?

A growing body of evidence suggests that inflammation in the brain is implicated in the development of Alzheimer's.


New Funding for Italian Biotechnology Company Exploring Novel Drugs for Alzheimer's Disease

The ADDF has awarded a follow-on grant to Axxam to further develop small molecule drugs to treat Alzheimer's disease by targeting inflammation.